Clinical Relevance of Impaired Physiological Assessment After Percutaneous Coronary Intervention: A Meta-analysis
- PMID: 39132337
- PMCID: PMC11307483
- DOI: 10.1016/j.jscai.2022.100448
Clinical Relevance of Impaired Physiological Assessment After Percutaneous Coronary Intervention: A Meta-analysis
Abstract
Background: Despite the optimal angiographic result of percutaneous coronary intervention (PCI), residual disease at the site of the culprit lesion can lead to major adverse cardiac events. Post-PCI physiological assessment can identify residual stenosis. This meta-analysis aims to investigate data of studies examining post-PCI physiological assessment in relation to long-term outcomes.
Methods: Studies were included in the meta-analysis after performing a systematic literature search on July 1, 2022. The primary end point was the incidence of major adverse cardiac events, vessel-orientated cardiac events, or target vessel failure.
Results: Low post-PCI fractional flow reserve, reported in 7 studies with fractional flow reserve cutoff values between 0.84 and 0.90, including 4017 patients, was associated with an increased rate of the primary end point (hazard ratio [HR], 2.06; 95% CI, 1.37-3.08). One study reported about impaired post-PCI instantaneous wave-free ratio with instantaneous wave-free ratio cutoff value of 0.95 in relation to major adverse cardiac events, showing a significant association (HR, 3.38; 95% CI, 0.99-11.6; P = .04). Low post-PCI quantitative flow ratio, reported in 3 studies with quantitative flow ratio cutoff value between 0.89 and 0.91, including 1181 patients, was associated with an increased rate of vessel-orientated cardiac events (HR, 3.01; 95% CI, 2.10-4.32). Combining data of all modalities, impaired physiological assessment showed an increased rate of the primary end point (HR, 2.32; 95% CI, 1.71-3.16) and secondary end points, including death (HR, 1.41; 95% CI, 1.04-1.89), myocardial infarction (HR, 2.70; 95% CI, 1.34-5.42) and target vessel revascularization (HR, 2.88; 95% CI, 1.91-4.35).
Conclusions: Impaired post-PCI physiological assessment is associated with increased adverse cardiac events and individual end points, including death, myocardial infarction, and target vessel revascularization. Therefore, prospective studies are awaited on whether physiology-based optimization of PCI results in better clinical outcomes.
Keywords: fractional flow reserve; instantaneous wave-free ratio; major adverse cardiac events; percutaneous coronary intervention; physiological assessment; quantitative flow ratio.
© 2022 The Author(s).
Figures







Similar articles
-
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis.Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):99-108. doi: 10.1093/ehjqcco/qcac053. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36026514
-
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).Circ Cardiovasc Interv. 2017 Apr;10(4):e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460. Circ Cardiovasc Interv. 2017. PMID: 28404623 Clinical Trial.
-
Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Sep 1;5(9):e2232842. doi: 10.1001/jamanetworkopen.2022.32842. JAMA Netw Open. 2022. PMID: 36136329 Free PMC article.
-
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.Circ Cardiovasc Interv. 2022 Nov;15(11):884-891. doi: 10.1161/CIRCINTERVENTIONS.122.012542. Epub 2022 Sep 19. Circ Cardiovasc Interv. 2022. PMID: 36121706 Clinical Trial.
-
Clinical and Prognostic Impact From Objective Analysis of Post-Angioplasty Fractional Flow Reserve Pullback.JACC Cardiovasc Interv. 2021 Sep 13;14(17):1888-1900. doi: 10.1016/j.jcin.2021.07.014. JACC Cardiovasc Interv. 2021. PMID: 34503739
Cited by
-
Association between post-PCI vessel fractional flow reserve (vFFR) and optical coherence tomography (OCT) findings: Results from the FAST OCT study.Int J Cardiol Heart Vasc. 2025 Jun 21;59:101706. doi: 10.1016/j.ijcha.2025.101706. eCollection 2025 Aug. Int J Cardiol Heart Vasc. 2025. PMID: 40612540 Free PMC article.
-
Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio: Post Hoc Analysis From FLAVOUR Trial.JACC Asia. 2025 Jan 7;5(1):59-70. doi: 10.1016/j.jacasi.2024.10.019. eCollection 2025 Jan. JACC Asia. 2025. PMID: 39886193 Free PMC article.
-
Enhancing PCI Outcomes With Postprocedural Murray Law-Based Quantitative Flow Ratio: A Step Forward in Physiological Assessment.JACC Asia. 2025 Jan 7;5(1):71-73. doi: 10.1016/j.jacasi.2024.11.011. eCollection 2025 Jan. JACC Asia. 2025. PMID: 39886198 Free PMC article.
-
Prognostic Value of Post-PCI Angiography-Derived Fractional Flow Reserve: A Systematic Review and Meta-Analysis of Cohort Studies.J Pers Med. 2023 Aug 12;13(8):1251. doi: 10.3390/jpm13081251. J Pers Med. 2023. PMID: 37623501 Free PMC article. Review.
References
-
- Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334(26):1703–1708. - PubMed
-
- Lee J.M., Choi K.H., Park J., et al. Physiological and clinical assessment of resting physiological indexes. Circulation. 2019;139(7):889–900. - PubMed
-
- Tonino P.A.L., De Bruyne B., Pijls N.H., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213–224. - PubMed
-
- Valgimigli M., Tebaldi M., Borghesi M., et al. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY) JACC Cardiovasc Interv. 2014;7(1):20–28. - PubMed
-
- Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–235. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous